Clinical Trial Update: Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update reports the completion of a study evaluating Vandetanib combined with Everolimus in patients with advanced, metastatic, recurren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Everolimus (everolimus)
• Vandetanib (vandetanib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm | Phase 1 | Status: COMPLETED